Abaxis gets FDA clearance for CRP test

01/21/2010 | ABC News

Abaxis, a provider of blood analysis systems, said it has obtained an FDA marketing clearance for its C-Reactive Protein assay. The test, which complements the company's Piccolo Xpress system, can detect infections, inflammatory diseases, tissue injuries and abnormal cell growth in under 12 minutes, Abaxis said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR